Tag: Cervical cancer

Genmab, Pfizer’s tisotumab vedotin takes a leap towards EU approval for cervical cancer

businessnewstoday- February 5, 2024

In a significant development for cervical cancer treatment, Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have announced the European Medicines Agency's (EMA) validation ... Read More

Model turned reality TV star Poonam Pandey passes away, leaving a legacy shrouded in mystery

businessnewstoday- February 3, 2024

In an announcement that has sent shockwaves across the entertainment landscape, Poonam Pandey, the model turned reality TV star, has succumbed to cervical cancer, as ... Read More

FDA approves Merck’s KEYTRUDA for advanced cervical cancer treatment

businessnewstoday- January 14, 2024

Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA) for KEYTRUDA, its ... Read More

Regeneron gets Libtayo approval in Japan for advanced cervical cancer

Raghuram Kadari- December 31, 2022

Regeneron Pharmaceuticals has secured the approval of the Japanese Ministry of Health, Labor and Welfare (MHLW) to manufacture and market the company’s Libtayo (cemiplimab) for ... Read More

Roche cobas HPV test for cervical screening gets FDA nod for use on cobas 6800/8800 Systems

pharmanewsdaily- April 25, 2020

Swiss healthcare company Roche has bagged approval from the US Food and Drug Administration to use its cobas HPV test on the fully automated cobas ... Read More

FDA lifts clinical hold on Advaxis’ Axalimogene Filolisbac, Durvalumab combo trial

pharmanewsdaily- July 15, 2018

Advaxis revealed that the US Food and Drug Administration (FDA) has removed a previously imposed clinical hold on its Phase 1/2 trial of Axalimogene Filolisbac ... Read More